Researchers identify target to help protect kidney patients' heart health

Blocking the endothelin receptor reduces risk factors for heart disease, the most common cause of death in kidney disease patients

2012-12-14

(Press-News.org) Highlights

Blocking the receptor for endothelin lowers novel cardiovascular risk factors in patients with chronic kidney disease independent of blood pressure. The findings suggest that blocking the receptor may provide heart-related benefits to these patients. 60 million people globally have chronic kidney disease.

Washington, DC (December 13, 2012) — Blocking the receptor for proteins that constrict blood vessels reduces markers of heart-related problems in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings might be used to improve the health of patients with CKD, who most often die from cardiovascular disease.

Patients with CKD have an increased risk of developing heart problems, in part because kidney disease can cause their arteries to stiffen. This is thought to occur due to an impaired availability of a vasodilator—nitric oxide (NO)—in the blood. The protein endothelin-1 is a vasoconstrictor and opposes the actions of NO, suggesting that drugs that block its effects may help protect CKD patients' heart health. One such drug is called sitaxentan, which blocks endothelin-1's receptor (called the ETA receptor).

Neeraj Dhaun, MD, PhD (University of Edinburgh, in Scotland) and his colleagues conducted a randomized, double-blind study in 27 patients with CKD to compare the effects of sitaxentan, nifedipine (a blood vessel relaxant), and placebo on kidney function, blood pressure, arterial stiffness, and various heart-related markers.

Among the major findings after six weeks of treatment: Placebo and nifedipine did not affect three markers of heart-related problems: blood levels of uric acid; blood levels of asymmetric dimethylarginine (ADMA), a blocker of NO production; and urine levels of endothelin-1. Sitaxentan treatment led to statistically significant reductions in all three of these markers. Sitaxentan reduced proteinuria (an excess excretion of protein in the urine) to a significantly greater extent than nifedipine. Proteinuria is an indicator of kidney dysfunction. Nifedpine and sitaxentan both reduced blood pressure to a similar extent.

"The current study shows, for the first time, that ETA receptor antagonism selectively lowers novel cardiovascular risk factors in patients with kidney disease independent of blood pressure. These effects were seen in patients already receiving optimal treatment," said Dr. Dhaun. "These findings suggest a potential role for ETA receptor antagonism in conferring additional longer-term cardiovascular and renal benefits in patients with kidney disease," he added.

### Study co-authors include: Vanessa Melville, RN, Scott Blackwell, MD, Dinesh Talwar, PhD, Neil Johnston, MSc, Jane Goddard, MD, PhD, and David Webb, MD, FRCP.

Disclosures: This study was funded by Encysive Pharmaceuticals and Pfizer. Drs. Dhaun, Goddard, and Webb have all received research grants from Pfizer. Drs. Dhaun and Goddard have held academic research fellowships funded by educational grants from Pfizer. Drs. Goddard and Webb have acted as Consultants to Pfizer.

Sitaxentan has been voluntarily withdrawn by Pfizer, Ltd due to unacceptable side effects. However, the findings of this study are likely to be representative of the effects of the class of selective endothelin A receptor antagonists.

The article, entitled "Endothelin-A Receptor Antagonism Modifies Cardiovascular Risk Factors in CKD," will appear online on at http://jasn.asnjournals.org/ December 13, 2012, doi: 10.1681/2012040355.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

ELSE PRESS RELEASES FROM THIS DATE:

More bang for bugs

2012-12-14

A new study from the rainforests of Panama provides an unprecedented level of detail regarding the diversity and distribution of arthropod species from the soil to the forest canopy. Yves Basset, scientific coordinator of the CTFS Arthropod Initiative at the Smithsonian Tropical Research Institute, led an international team on Project IBISCA-Panama to sample, sort, catalogue, and finally estimate that a 6,000 hectare forest hosts a total of around 25,000 arthropod species – a figure vastly outnumbering that of better-studied organisms. The study will be published online ...

Psychosocial distress associated with increased stroke risk

2012-12-14

People over age 65 with high psychosocial distress face increased risk of stroke, according to new research in the American Heart Association journal Stroke. Psychosocial distress is a broad concept that includes depression, stress, a negative outlook and dissatisfaction with life. In their 10-year study, researchers followed 4,120 people in the Chicago Health and Aging Project for rates of death and stroke incidents. Due to some participants being involved in an HMO only 2,649 participants were analyzed for rates of incident stroke. Participants were 65 years and older ...

Building better structural materials

2012-12-14

Washington, D.C. — When materials are stressed, they eventually change shape. Initially these changes are elastic, and reverse when the stress is relieved. When the material's strength is exceeded, the changes become permanent. This could result in the material breaking or shattering, but it could also re-shape the material, such as a hammer denting a piece of metal. Understanding this last group of changes is the focus of research from a team including Carnegie's Ho-kwang "Dave" Mao. Their breakthrough research on the behavior nickel nanocrystals under intense pressure ...

Data on financial crime is not credible

2012-12-14

The Government and police efforts to tackle financial crime – from business fraud to tax evasion – are hampered by a lack of accurate data about the nature and extent of offending, according to new research. Most of the data available on financial crime is produced without a credible methodology, says Michael Levi, Professor of Criminology at Cardiff University, whose research was funded by the Economic and Social Research Council (ESRC). "Typically, the information available on offending or threat is just a marketing hype," says Professor Levi. "It comes from business ...

Pheromone helps mice remember where to find a mate

2012-12-14

Scientists at the University of Liverpool have found that male mice produce a pheromone that provokes females and competitor males to remember a preference for the place where the pheromone was previously encountered. Some animals, such as moths, use a sensitive tracking system to trace airborne sex pheromones to the source, while others, such as snakes, follow trails of pheromones left on the ground. A team from the University's Institute of Integrative Biology has discovered that mice use a different system to locate mates and competitors by remembering exactly where ...

Reality check for DNA nanotechnology

2012-12-14

Two major barriers to the advancement of DNA nanotechnology beyond the research lab have been knocked down. This emerging technology employs DNA as a programmable building material for self-assembled, nanometer-scale structures. Many practical applications have been envisioned, and researchers recently demonstrated a synthetic membrane channel made from DNA. Until now, however, design processes were hobbled by a lack of structural feedback. Assembly was slow and often of poor quality. Now researchers led by Prof. Hendrik Dietz of the Technische Universitaet Muenchen (TUM) ...

Vitamin D can help infection-prone patients avoid respiratory tract infection

2012-12-14

Treating infection-prone patients over a 12-month period with high doses of vitamin D reduces their risk of developing respiratory tract infection – and consequently their antibiotic requirement. This according to a new study by researchers at Karolinska Institutet and Karolinska University Hospital published in the online scientific journal BMJ Open. "Our research can have important implications for patients with recurrent infections or a compromised immune defence, such as a lack of antibodies, and can also help to prevent the emerging resistance to antibiotics that ...

Ebola virus uses a protein decoy to subvert the host immune response

2012-12-14

In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its infected host. Ebola virus is the causative agent of Ebola Hemorrhagic Fever (EHF), a disease with up to 90 percent mortality. While human outbreaks of Ebola hemorrhagic fever have been confined to Africa, Ebola virus infections in bats, the presumed natural reservoir of the virus, have also been detected in Europe and Asia. The high lethality of ...

Climate warming unlikely to cause near-term extinction of Amazon trees, but threats remain

2012-12-14

ANN ARBOR — A new genetic analysis has revealed that many Amazon tree species are likely to survive human-caused climate warming in the coming century, contrary to previous findings that temperature increases would cause them to die out. However, the authors of the new study warn that extreme drought and forest fires will impact Amazonia as temperatures rise, and the over-exploitation of the region's resources continues to be a major threat to its future. Conservation policy for the Amazon should remain focused on reducing global greenhouse-gas emissions and preventing ...

The aging immune system is more functional than previously believed

2012-12-14

In a study published today in the Open Access journal PLOS Pathogens, scientists at McMaster University in Hamilton, Ontario have determined that a specialized class of immune cells, known as T cells, retains its functionality with age and can respond to virus infections with the same vigor as T cells from a young person. This is a valuable finding as it is generally believed that elderly individuals are at increased risk of infection because immunity deteriorates with age. T cells play an important role in defending the body from virus infections. For a long time, ...

Researchers identify target to help protect kidney patients' heart health

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: